Nitroglycerin and heterogeneity of myocardial blood flow. Reduced subendocardial blood flow and ventricular contractile force

The Journal of Clinical Investigation
R FormanE H Sonnenblick

Abstract

The effects of both intracoronary and intravenous administration of nitroglycerin on transmural distribution of blood flow in the left ventricle after partial coronary artery occlusion was investigated using two independent methods. In 16 open chest, anesthetized dogs, tubing supplying the cannulated left coronary artery was partially occluded. Strain gauges sutured paralled to superficial and deep fibers of the myocardium separately recorded the contractile force of each layer. With occlusion set so that depression of the deep contractile force was imminent. 12 mug intracoronary nitroglycerin in seven dogs depressed only the deep contractile force without changing systemic hemodynamics. Intravenous administration of 180 mug nitroglycerin in nine dogs resulted in a decrease of deep contractile force and aortic pressure often associated with an increase in superficial contractile force. Distribution of myocardial blood flow during peak coronary flow after intracoronary administration of nitroglycerin or during a decrease in aortic pressure after intravenous nitroglycerin administration was determined by the tissue uptake of an intracoronary bolus of rubidium-(80). This was compared with the uptake of potassium-(42) injected befo...Continue Reading

References

Mar 1, 1969·Circulation Research·D D StreeterE H Sonnenblick
Nov 1, 1963·American Heart Journal·P F SALISBURYP A RIEBEN
Jul 23, 1955·Journal of the American Medical Association·H I RUSSEKB L ZOHMAN

Citations

Jan 1, 1978·Catheterization and Cardiovascular Diagnosis·E L FallenP H Tanser
Nov 15, 1977·European Journal of Pharmacology·J M Downey
Jul 1, 1986·Journal of the American College of Cardiology·K L Gould
Jul 1, 1987·Journal of the American College of Cardiology·C Eng, E H Sonnenblick
Nov 1, 1973·The Journal of Clinical Investigation·M V CohenE S Kirk
Jun 1, 1978·American Heart Journal·H D Sostman, R A Langou
Jun 1, 1979·American Heart Journal·P E ParkerI S Boutros
Jul 1, 1980·The American Journal of Cardiology·K P GallagherG G Rowe
Dec 1, 1978·The American Journal of Cardiology·A S MostR W Millard
Sep 15, 1990·The American Journal of Cardiology·B P KimballN Dafopoulos
May 1, 1987·Progress in Cardiovascular Diseases·J I Hoffman
Jul 1, 1985·American Heart Journal·J Abrams
Mar 31, 1976·The American Journal of Cardiology·P L da Luz, J S Forrester
Jan 1, 1991·The Journal of Surgical Research·M C StirlingK P Gallagher
Apr 1, 1981·American Heart Journal·D O Williams
Oct 6, 1975·The American Journal of Cardiology·J G DumesnilR L Frye
May 31, 1976·The American Journal of Medicine·R H Helfant
Jan 1, 1982·International Journal of Cardiology·W P SantamoreR A Carey
Mar 1, 1974·Circulation Research·J M DowneyE S Kirk
Sep 1, 1983·Basic Research in Cardiology·J WichmannK Kochsiek
Aug 1, 1980·Anaesthesia and Intensive Care·M J Brown

Related Concepts

Metazoa
Diastolic Blood Pressure
Coronary Circulation
Canis familiaris
Trinitrolong
Left Ventricular Structure
Intravenous Injections
Potassium Isotopes
Radioisotopes
Rubidium

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.